Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$8,535,168
+$85,139 QoQ
Shares Held
23,570
-1.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#609
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. AMGN ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
This page
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,535,168 | 23,570 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $8,450,029 | 24,016 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $8,445,579 | 25,803 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,368,524 | 26,111 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $7,327,587 | 26,244 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $8,003,407 | 25,689 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $6,644,234 | 25,492 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,284,019 | 25,710 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $8,336,790 | 26,682 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,675,218 | 26,995 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,106,322 | 28,145 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $7,438,201 | 27,676 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,814,037 | 26,187 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,595,181 | 27,281 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,843,347 | 26,056 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,760,773 | 25,558 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,527,495 | 26,829 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,579,438 | 27,208 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,215,471 | 27,628 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $5,914,434 | 27,813 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,989,043 | 28,673 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,435,686 | 29,885 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,060,613 | 30,709 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,747,050 | 30,481 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,192,550 | 30,495 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,456,342 | 31,847 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||